# Byoung Chul Cho, M.D., Ph.D. – FDA Inspection, Apr 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/byoung-chul-cho-md-phd/6d80fb00-4ad0-4e59-b635-5143bcd9d519
Source feed: FDA_Inspections

> FDA inspection 1092851 of Byoung Chul Cho, M.D., Ph.D., April 26, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092851
- Company Name: Byoung Chul Cho, M.D., Ph.D.
- Inspection Date: 2019-04-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1230852 - 2024-02-02
- FDA Inspection 1172440 - 2022-05-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/byoung-chul-cho-md-phd/fc87b816-061b-4330-8688-434a8f313f8d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c